Innova Captab Ltd

Innova Captab Ltd Share Price Today: Live Updates & Key Insights

Get insights on Innova Captab Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Innova Captab Ltd Share Price Chart

Innova Captab Ltd Fundamentals

Traded Volume: 37,307

Market Cap(Cr): 4,346

Avg Traded Price 747.10

1 Year return -21.61%

Upper Circuit 770

Lower Circuit 717

P/E TTM 35.00

P/B Ratio 22.00

Traded Value(Cr) 283.33

EPS TTM 21.750

Book value 21.750

Dividend 0.00%

Innova Captab Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Innova Captab Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Innova Captab Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W +4.02%

1M -4.77%

3M -15.64%

1Y -21.61%

YTD -34.01%

Innova Captab Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Innova Captab Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 34644.00

Day Before Yesterday 36277.00

1W Avg 34447.00

1M Avg 26986.00

3M Avg 32746.08

Innova Captab Ltd Technical Details

Innova Captab Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 null

Support 2 null

Support 3 null

Pivot Point : null

Resistance 1 null

Resistance 2 null

Resistance 3 null

Innova Captab Ltd Corporate Actions

Innova Captab Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Innova Captab Ltd’s capital allocation strategies.

All

Dividends

No Dividend has been declared by INNOVACAP

Bonus

No Bonus has been declared by INNOVACAP

Splits

No Split has been declared by INNOVACAP

Others

Rights No Rights has been declared by INNOVACAP

Innova Captab Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Innova Captab Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Innova Captab Ltd's relative performance and valuation against major competitors.

Stock Name Gujarat Themis Biosyn Ltd ₹412.70 (-2.40%) M. Cap (Cr) 44.97 1 Yr Return (%) +28.32% P/E (TTM) 93.12 PB Ratio 20.13

Stock Name Sun Pharma Advanced Research Company Ltd ₹136.01 (-1.48%) M. Cap (Cr) 44.14 1 Yr Return (%) -28.54% P/E (TTM) -16.53 PB Ratio -57.04

Stock Name Orchid Pharma Ltd ₹866.40 (-0.38%) M. Cap (Cr) 43.94 1 Yr Return (%) -41.36% P/E (TTM) 84.09 PB Ratio 3.59

Stock Name Innova Captab Ltd ₹759.45 (+3.73%) M. Cap (Cr) 43.46 1 Yr Return (%) -21.61% P/E (TTM) 34.92 PB Ratio 4.53

Stock Name Aarti Drugs Ltd ₹442.10 (-1.05%) M. Cap (Cr) 40.64 1 Yr Return (%) -2.78% P/E (TTM) 20.27 PB Ratio 3.16

Stock Name Senores Pharmaceuticals Ltd ₹819.55 (-0.75%) M. Cap (Cr) 37.74 1 Yr Return (%) NaN% P/E (TTM) 43.32 PB Ratio 4.80

Stock Name Dishman Carbogen Amcis Ltd ₹237.95 (-3.33%) M. Cap (Cr) 37.31 1 Yr Return (%) +8.89% P/E (TTM) 27.35 PB Ratio 0.65

Innova Captab Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Innova Captab Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 19.80 Mar 2024 111.67 Mar 2023 39.28 Mar 2022 58.34 Mar 2021 41.56

PARTICULARS Investing Activities Mar 2025 -99.75 Mar 2024 -471.55 Mar 2023 -87.53 Mar 2022 -188.33 Mar 2021 -19.67

PARTICULARS Financing Activities Mar 2025 83.86 Mar 2024 368.13 Mar 2023 51.29 Mar 2022 125.30 Mar 2021 -19.34

PARTICULARS Net Cash Flow Mar 2025 3.92 Mar 2024 8.25 Mar 2023 3.03 Mar 2022 -4.69 Mar 2021 2.56

Innova Captab Ltd Shareholding Pattern

This shows the ownership breakdown of Innova Captab Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 50.9%

Public 28.86%

Other Institutions 9.48%

FII 0.08%

Mutual Funds 10.69%

About Innova Captab Ltd

Innova Captab Limited was incorporated as `Harun Health Care Private Limited', dated January 3, 2005, as a Private Limited Company at Mumbai. Thereafter, the name of the Company was changed from `Harun Health Care Private Limited' to `Innova Captab Private Limited', and a fresh Certificate of Incorporation dated February 2, 2010, was issued by RoC to the Company. Subsequently, Company got converted to a Public Company on July 12, 2018, and the name was changed to `Innova Captab Limited', dated July 26, 2018.The Company is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports. Their business includes contract development and manufacturing organization (CDMO) business providing manufacturing services to Indian pharmaceutical companies, domestic branded generics business and an international branded generics business. Their CDMO product portfolio spans across both acute and chronic therapeutic areas. These CDMO services and products include commercial large-scale manufacturing of generic products, which allow customers in offering multiple dosage forms, including oral solids, oral liquids, dry syrups and injectables, modified and release forms of tablets in capsules. It has 2 manufacturing facilities in Baddi, Himachal Pradesh. Their facilities further produce tablets, capsules, dry syrups, dry powder injections, ointments and liquid orals. In 2006, the first manufacturing plant got established in Baddi, at Himachal Pradesh. In 2010, it commenced operations at the cephalosporin block of their plant in Baddi. In 2021, the Company acquired business of Innova Captab, a Partnership Firm, as a going concern through Slump Sale effective in March, 2021 and acquired Univentis Medicare Limited (UML) 100% equity shares effective on December 31, 2021 and consequently, The Univentis Foundation became a Subsidiary of Company on June 14, 2021.The Company commenced construction to establish an industrial plant in Jammu and Kashmir and to build an R&D center in Panchkula, Haryana in 2022. In December 2023, the Company came up with an IPO aggregating to Rs 570 Crores by issuing 12,723,214 Equity Shares, comprising 7,142,857 Equity Shares aggregating to Rs 320 Crore through Fresh Issue and 5,580,357 Equity Shares aggregating to Rs 250 Crore through Offer for Sale. The Company acquired Sharon Bio-Medicine Limited in June, 2023. In 2024-25, Company commissioned a new greenfield facility in Kathua, Jammu w.e.f. 14 January, 2025.

Whole-time Director

JAYANT VASUDEO RAO

Registered office Office No 1513 Satra Plaza, Plot No 19-20 Sector 19D Vashi, Navi Mumbai, Maharashtra, 400703

FAX :91-22-2564 2095

Background

Incorporation Year 2005

Face Value ₹10.00

Market Lot 1

Innova Captab Ltd Latest News

VIEW MORE NEWS

FAQs on Innova Captab Ltd